Bioactive peptide-modified biomaterials for bone regeneration

Current Pharmaceutical Design

Volumn 17, Issue 25, 2011, Pages 2663-2676

  Lee, Jue Yeon ^a   Choi, Young Suk ^a   Lee, Seung Jin ^b   Chung, Chong Pyoung ^a   Park, Yoon Jeong ^a  

^a School of Dentistry   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Bioactive peptide; Biomaterials; Bone regeneration; Ecm (extracellular matrix); Tissue engineering

Indexed keywords

BIOMATERIAL; GROWTH FACTOR; PEPTIDE DERIVATIVE; TISSUE SCAFFOLD;

BIODEGRADATION; BIOMINERALIZATION; BONE REGENERATION; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

EID: 80053493939     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211797416011     Document Type: Review

References (107)

1. Sreejalekshmi KG, Nair PD. Biomimeticity in tissue engineering scaffolds through synthetic peptide modifications-Altering chemistry for enhanced biological response. J Biomed Mater Res A, 2010.
2. [JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet, 1999; 354 Suppl 1: SI32-4.
3. Schieker M, Mutschler W. [Bridging posttraumatic bony defects. Established and new methods]. Unfallchirurg, 2006; 109: 715-32.
4. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials, 1996; 17: 175-85.
5. Wiesmann HP, Joos U, Meyer U. Biological and biophysical principles in extracorporal bone tissue engineering. Part II. Int J Oral Maxillofac Surg, 2004; 33: 523-30.
6. Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials, 2000; 21: 2347-59.
7. [Croteau S, Rauch F, Silvestri A, Hamdy RC. Bone morphogenetic proteins in orthopedics: from basic science to clinical practice. Orthopedics, 1999; 22: 686-95; quiz 696-7.
8. Harakas NK. Demineralized bone-matrix-induced osteogenesis. Clin Orthop Relat Res, 1984: 239-51.
9. Hubbell JA. Biomaterials in tissue engineering. Biotechnology (N Y), 1995; 13: 565-76.
10. Vacanti JP, Langer R, Upton J, Marler JJ. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev, 1998; 33: 165-182.
11. Murphy WL, Mooney DJ. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J Periodontal Res, 1999; 34: 413-9.
12. Devescovi V, Leonardi E, Ciapetti G, Cenni E. Growth factors in bone repair. Chir Organi Mov, 2008; 92: 161-8.
13. Benoit DS, Anseth KS. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials, 2005; 26: 5209-20.
14. Holmes TC, de Lacalle S, Su X, Liu G, Rich A, Zhang S. Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. Proc Natl Acad Sci USA, 2000; 97: 6728-33.
15. Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol, 1986; 103: 2637-47.
16. Koivunen E, Wang B, Dickinson CD, Ruoslahti E. Peptides in cell adhesion research. Methods Enzymol, 1994; 245: 346-69.
17. Vukicevic S, Luyten FP, Kleinman HK, Reddi AH. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell, 1990; 63: 437-45.
18. Aota S, Nagai T, Yamada KM. Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem, 1991; 266: 15938-43.
19. Dalton BA, McFarland CD, Underwood PA, Steele JG. Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. J Cell Sci, 1995; 108 (Pt 5): 2083-92.
20. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials, 2003; 24: 4353-64.
21. Green J, Schotland S, Stauber DJ, Kleeman CR, Clemens TL. Cellmatrix interaction in bone: type I collagen modulates signal transduction in osteoblast-like cells. Am J Physiol, 1995; 268: C1090-103.
22. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res, 1996; 31: 545-54.
23. Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM, Smith N. Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng, 1999; 5: 53-65.
24. Bhatnagar RS, Qian JJ, Gough CA. The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1 (I) chain: structural and biological evidence for conformational tautomerism on fiber surface. J Biomol Struct Dyn, 1997; 14: 547-60.
25. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Multi-center clinical comparison of combination anorganic bovinederived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol, 2000; 71: 1671-9.
26. Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun, 2003; 311: 179-86.
27. Thorwarth M, Schultze-Mosgau S, Wehrhan F, Srour S, Wiltfang J, Neukam FW, Schlegel KA. Enhanced bone regeneration with a synthetic cell-binding peptide--in vivo results. Biochem Biophys Res Commun, 2005; 329: 789-95.
28. Hennessy KM, Pollot BE, Clem WC, Phipps MC, Sawyer AA, Culpepper BK, Bellis SL. The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials, 2009; 30: 1898-909.
29. Reyes CD, Garcia AJ. Alpha2beta1 integrin-specific collagenmimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res A, 2004; 69: 591-600.
30. Reyes CD, Petrie TA, Burns KL, Schwartz Z, Garcia AJ. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials, 2007; 28: 3228-35.
31. McCann TJ, Mason WT, Meikle MC, McDonald F. A collagen peptide motif activates tyrosine kinase-dependent calcium signalling pathways in human osteoblast-like cells. Matrix Biol, 1997; 16: 273-83.
32. Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem, 1991; 266: 7363-7.
33. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. Faseb J, 1993; 7: 1475-82.
34. McKee MD, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech, 1996; 33: 141-64.
35. Fujisawa R, Nodasaka Y, Kuboki Y. Further characterization of interaction between bone sialoprotein (BSP) and collagen. Calcif Tissue Int, 1995; 56: 140-4.
36. He G, George A. Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro. J Biol Chem, 2004; 279: 11649-56.
37. [Dahl T, Veis A. Electrostatic interactions lead to the formation of asymmetric collagen-phosphophoryn aggregates. Connect Tissue Res, 2003; 44 Suppl 1: 206-13.
38. Fujisawa R, Kuboki Y. Affinity of bone sialoprotein and several other bone and dentin acidic proteins to collagen fibrils. Calcif Tissue Int, 1992; 51: 438-42.
39. Boskey AL. Matrix proteins and mineralization: an overview. Connect Tissue Res, 1996; 35: 357-63.
40. Saito T, Arsenault AL, Yamauchi M, Kuboki Y, Crenshaw MA. Mineral induction by immobilized phosphoproteins. Bone, 1997; 21: 305-11.
41. Rocha LB, Adam RL, Leite NJ, Metze K, Rossi MA. Biomineralization of polyanionic collagen-elastin matrices during cavarial bone repair. J Biomed Mater Res A, 2006; 79: 237-45.
42. Lee JY, Choo JE, Choi YS, Park JB, Min DS, Lee SJ, Rhyu HK, Jo IH, Chung CP, Park YJ. Assembly of collagen-binding peptide with collagen as a bioactive scaffold for osteogenesis in vitro and in vivo. Biomaterials, 2007; 28: 4257-67.
43. Lee JY, Choo JE, Park HJ, Park JB, Lee SC, Jo I, Lee SJ, Chung CP, Park YJ. Injectable gel with synthetic collagen-binding peptide for enhanced osteogenesis in vitro and in vivo. Biochem Biophys Res Commun, 2007; 357: 68-74.
44. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials, 1999; 20: 45-53.
45. Lai CF, Seshadri V, Huang K, Shao JS, Cai J, Vattikuti R, Schumacher A, Loewy AP, Denhardt DT, Rittling SR, Towler DA. An osteopontin-NADPH oxidase signaling cascade promotes promatrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res, 2006; 98: 1479-89.
46. Hamada Y, Egusa H, Kaneda Y, Hirata I, Kawaguchi N, Hirao T, Matsumoto T, Yao M, Daito K, Suzuki M, Yatani H, Daito M, Okazaki M, Matsuura N. Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials. Dent Mater J, 2007; 26: 487-92.
47. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater, 2008; 15: 100-14.
48. Egusa H, Kaneda Y, Akashi Y, Hamada Y, Matsumoto T, Saeki M, Thakor DK, Tabata Y, Matsuura N, Yatani H. Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts. Biomaterials, 2009; 30: 4676-86.
49. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int, 1991; 49: 421-6.
50. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog, 1999; 15: 19-32.
51. Dee KC, Andersen TT, Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J Biomed Mater Res, 1998; 40: 371-7.
52. Nelson M, Balasundaram G, Webster TJ. Increased osteoblast adhesion on nanoparticulate crystalline hydroxyapatite functionalized with KRSR. Int J Nanomedicine, 2006; 1: 339-49.
53. Robey PG, Young MF, Fisher LW, McClain TD. Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J Cell Biol, 1989; 108: 719-27.
54. Fisher LW, Whitson SW, Avioli LV, Termine JD. Matrix sialoprotein of developing bone. J Biol Chem, 1983; 258: 12723-7.
55. Obara M, Kang MS, Yamada KM. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell, 1988; 53: 649-57.
56. Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol, 1998; 10: 220-31.
57. Dee KC, Rueger DC, Andersen TT, Bizios R. Conditions which promote mineralization at the bone-implant interface: a model in vitro study. Biomaterials, 1996; 17: 209-15.
58. Mertz PM, Davis SC, Franzen L, Uchima FD, Pickett MP, Pierschbacher MD, Polarek JW. Effects of an arginine-glycineaspartic acid peptide-containing artificial matrix on epithelial migration in vitro and experimental second-degree burn wound healing in vivo. J Burn Care Rehabil, 1996; 17: 199-206.
59. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J Biomed Mater Res, 1997; 37: 9-19.
60. Puleo DA, Bizios R. RGDS tetrapeptide binds to osteoblasts and inhibits fibronectin-mediated adhesion. Bone, 1991; 12: 271-6.
61. Rezania A, Healy KE. The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. J Biomed Mater Res, 2000; 52: 595-600.
62. Shin H, Zygourakis K, Farach-Carson MC, Yaszemski MJ, Mikos AG. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg- Gly-Asp containing peptides. J Biomed Mater Res A, 2004; 69: 535-43.
63. Gilbert M, Shaw WJ, Long JR, Nelson K, Drobny GP, Giachelli CM, Stayton PS. Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J Biol Chem, 2000; 275: 16213-8.
64. Ferris DM, Moodie GD, Dimond PM, Gioranni CW, Ehrlich MG, Valentini RF. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials, 1999; 20: 2323-31.
65. Glass JR, Dickerson KT, Stecker K, Polarek JW. Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix. Biomaterials, 1996; 17: 1101-8.
66. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials, 1997; 18: 1201-25.
67. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res, 2005; 320: 269-76.
68. Tamai N, Myoui A, Hirao M, Kaito T, Ochi T, Tanaka J, Takaoka K, Yoshikawa H. A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2). Osteoarthritis Cartilage, 2005; 13: 405-17.
69. Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res A, 2004; 70: 115-21.
70. Saito A, Suzuki Y, Kitamura M, Ogata S, Yoshihara Y, Masuda S, Ohtsuki C, Tanihara M. Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alphatricalcium phosphate scaffold. J Biomed Mater Res A, 2006; 77: 700-6.
71. Kirsch T, Sebald W, Dreyer MK. Crystal structure of the BMP-2- BRIA ectodomain complex. Nat Struct Biol, 2000; 7: 492-6.
72. Nickel J, Dreyer MK, Kirsch T, Sebald W. The crystal structure of the BMP-2: BMPR-IA complex and the generation of BMP-2 antagonists. J Bone Joint Surg Am, 2001; 83-A Suppl 1: S7-14.
73. Lee JY, Choo JE, Park HJ, Park JB, Lee SC, Lee SJ, Park YJ, Chung CP. Synthetic peptide-coated bone mineral for enhanced osteoblastic activation in vitro and in vivo. J Biomed Mater Res A, 2008; 87: 688-97.
74. Park JB, Lee JY, Park HN, Seol YJ, Park YJ, Rhee SH, Lee SC, Kim KH, Kim TI, Lee YM, Ku Y, Rhyu IC, Han SB, Chung CP. Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo. J Periodontol, 2007; 78: 157-63.
75. Seol YJ, Park YJ, Lee SC, Kim KH, Lee JY, Kim TI, Lee YM, Ku Y, Rhyu IC, Han SB, Chung CP. Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2. J Biomed Mater Res A, 2006; 77: 599-607.
76. Choi YJ, Lee JY, Park JH, Park JB, Suh JS, Choi YS, Lee SJ, Chung CP, Park YJ. The identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesis. Biomaterials, 2010; 31: 7226-38.
77. Lee JY, Choo JE, Choi YS, Lee KY, Min DS, Pi SH, Seol YJ, Lee SJ, Jo IH, Chung CP, Park YJ. Characterization of the surface immobilized synthetic heparin binding domain derived from human fibroblast growth factor-2 and its effect on osteoblast differentiation. J Biomed Mater Res A, 2007; 83: 970-9.
78. McCarthy JB, Skubitz AP, Qi Z, Yi XY, Mickelson DJ, Klein DJ, Furcht LT. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparindependent and -independent activities. J Cell Biol, 1990; 110: 777-87.
79. Huebsch JB, Fields GB, Triebes TG, Mooradian DL. Photoreactive analog of peptide FN-C/H-V from the carboxy-terminal heparin binding domains of fibronectin supports endothelial cell adhesion and spreading on biomaterial surfaces. J Biomed Mater Res, 1996; 31: 555-67.
80. Lee JY, Choo JE, Choi YS, Shim IK, Lee SJ, Seol YJ, Chung CP, Park YJ. Effect of immobilized cell-binding peptides on chitosan membranes for osteoblastic differentiation of mesenchymal stem cells. Biotechnol Appl Biochem, 2009; 52: 69-77.
81. Geesink RG. Osteoconductive coatings for total joint arthroplasty. Clin Orthop Relat Res, 2002: 53-65.
82. Tanahashi M, Yao T, Kokubo T, Minoda M, Miyamoto T, Nakamura T, Yamamuro T. Apatite coated on organic polymers by biomimetic process: improvement in its adhesion to substrate by glow-discharge treatment. J Biomed Mater Res, 1995; 29: 349-57.
83. Gorski JP. Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calcif Tissue Int, 1992; 50: 391-6.
84. Johnsson M, Levine MJ, Nancollas GH. Hydroxyapatite binding domains in salivary proteins. Crit Rev Oral Biol Med, 1993; 4: 371-8.
85. Boskey AL. Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci, 1995; 760: 249-56.
86. Fujisawa R, Kuboki Y. Preferential adsorption of dentin and bone acidic proteins on the (100) face of hydroxyapatite crystals. Biochim Biophys Acta, 1991; 1075: 56-60.
87. Segvich SJ, Smith HC, Kohn DH. The adsorption of preferential binding peptides to apatite-based materials. Biomaterials, 2009; 30: 1287-98.
88. Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ, Mikos AG. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials, 1998; 19: 1405-12.
89. Fujisawa R, Mizuno M, Nodasaka Y, Kuboki Y. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol, 1997; 16: 21-8.
90. Dettin M, Conconi MT, Gambaretto R, Bagno A, Di Bello C, Menti AM, Grandi C, Parnigotto PP. Effect of synthetic peptides on osteoblast adhesion. Biomaterials, 2005; 26: 4507-15.
91. Murphy MB, Hartgerink JD, Goepferich A, Mikos AG. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules, 2007; 8: 2237-43.
92. Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, Goldberg HA. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem, 2003; 278: 7949-55.
93. Dahl T, Sabsay B, Veis A. Type I collagen-phosphophoryn interactions: specificity of the monomer-monomer binding. J Struct Biol, 1998; 123: 162-8.
94. He G, Dahl T, Veis A, George A. Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. Nat Mater, 2003; 2: 552-8.
95. Holmes TC. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol, 2002; 20: 16-21.
96. Zhang S. Fabrication of novel biomaterials through molecular selfassembly. Nat Biotechnol, 2003; 21: 1171-8.
97. Zhang S, Lockshin C, Cook R, Rich A. Unusually stable beta-sheet formation in an ionic self-complementary oligopeptide. Biopolymers, 1994; 34: 663-72.
98. Misawa H, Kobayashi N, Soto-Gutierrez A, Chen Y, Yoshida A, Rivas-Carrillo JD, Navarro-Alvarez N, Tanaka K, Miki A, Takei J, Ueda T, Tanaka M, Endo H, Tanaka N, Ozaki T. PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant, 2006; 15: 903-10.
99. Kirkham J, Firth A, Vernals D, Boden N, Robinson C, Shore RC, Brookes SJ, Aggeli A. Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res, 2007; 86: 426-30.
100. Genove E, Shen C, Zhang S, Semino CE. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials, 2005; 26: 3341-51.
101. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science, 2001; 294: 1684-8.
102. Traub W, Arad T, Weiner S. Three-dimensional ordered distribution of crystals in turkey tendon collagen fibers. Proc Natl Acad Sci USA, 1989; 86: 9822-6.
103. Hartgerink JD, Beniash E, Stupp SI. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of selfassembling materials. Proc Natl Acad Sci USA, 2002; 99: 5133-8.
104. Silva GA, Czeisler C, Niece KL, Beniash E, Harrington DA, Kessler JA, Stupp SI. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science, 2004; 303: 1352-5.
105. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in selfassembled peptide-amphiphile nanofibers. Biomaterials, 2006; 27: 4079-86.
106. [Sargeant TD, Guler MO, Oppenheimer SM, Mata A, Satcher RL, Dunand DC, Stupp SI. Hybrid bone implants: self-assembly of peptide amphiphile nanofibers within porous titanium. Biomaterials, 2008; 29: 161-71.
107. [Lee JY, Choo JE, Choi YS, Suh JS, Lee SJ, Chung CP, Park YJ. Osteoblastic differentiation of human bone marrow stromal cells in self-assembled BMP-2 receptor-binding peptide-amphiphiles. Biomaterials, 2009; 30: 3532-41.